Radiopharm Theranostics (RADX) Assets (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Assets for 2 consecutive years, with $86.5 million as the latest value for Q2 2025.
- Quarterly Assets rose 20.05% to $86.5 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $86.5 million through Jun 2025, up 20.05% year-over-year, with the annual reading at $86.5 million for FY2025, 20.05% up from the prior year.
- Assets for Q2 2025 was $86.5 million at Radiopharm Theranostics, up from $72.0 million in the prior quarter.
- The five-year high for Assets was $86.5 million in Q2 2025, with the low at $72.0 million in Q2 2024.